Suchergebnisse - "Goh, Boon-Cher"

PubPharm (369)

1

A glycolytic metabolite bypasses "two-hit" tumor suppression by BRCA2

enthalten in: Cell | 2024

von Kong, L. | Gupta, K. | Wu, A. | +22

2

Enhancer infestation drives tumorigenic activation of inactive B compartment in Epstein-Barr virus-positive nasopharyngeal carcinoma

enthalten in: EBioMedicine | 2024

von Mizokami, H. | Okabe, A. | Choudhary, R. | +15

3

Reactive Oxygen Species Modulation in the Current Landscape of Anticancer Therapies

enthalten in: Antioxidants & redox signaling | 2024

von Li, J. | Lim, J. | Eu, J. | +4

4

MODULATION OF SIGNAL TRANSDUCER AND ACTIVATOR OF TRANSCRIPTION 3 (STAT3) EXPRESSION

enthalten in: Europäisches Patentamt | 2024

von GOH BOON CHER | KONG LI REN

5

AKR1C3 in carcinomas : from multifaceted roles to therapeutic strategies

enthalten in: Frontiers in pharmacology | 2024

von Li, M. | Zhang, L. | Yu, J. | +6

6

Hyperphosphorylation of BCL-2 family proteins underlies functional resistance to venetoclax in lymphoid malignancies

enthalten in: The Journal of clinical investigation | 2023

von Chong, S. | Zhu, F. | Dashevsky, O. | +21

7

A Phase II Study of Osimertinib in Patients with Advanced-Stage Non-Small Cell Lung Cancer following Prior Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor (EGFR TKI) Therapy with EGFR and T790M Mutations Detected in Plasma Circulating Tumour DNA (PLASMA Study)

enthalten in: Cancers | 2023

von Ang, Y. | Zhao, X. | Reungwetwattana, T. | +17

8

Curcumin in cancer therapy : Exploring molecular mechanisms and overcoming clinical challenges

enthalten in: Cancer letters | 2023

von Wang, W. | Li, M. | Wang, L. | +2

9

A Phase I, First-in-Human Study of PRL3-zumab in Advanced, Refractory Solid Tumors and Hematological Malignancies

enthalten in: Targeted oncology | 2023

von Chee, C. | Ooi, M. | Lee, S. | +15

10

Clinical efficacy and biomarker analysis of dual PD-1/CTLA-4 blockade in recurrent/metastatic EBV-associated nasopharyngeal carcinoma

enthalten in: Nature communications | 2023

von Lim, D. | Kao, H. | Suteja, L. | +17

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[37]